Ge Long Hui A P P·2025-12-15 08:12Core Viewpoint - Shanghai Pharmaceuticals (601607.SH) announced that its subsidiary, Changzhou Pharmaceutical Factory, received a Drug Supplement Application Approval Notice from the National Medical Products Administration for its Sotalol Hydrochloride Tablets, which passed the consistency evaluation of generic drug quality and efficacy [1] Group 1 - The Sotalol Hydrochloride Tablets are primarily used for: 1) conversion and prevention of supraventricular tachycardia, especially atrioventricular nodal reentrant tachycardia; 2) atrial flutter and atrial fibrillation; 3) various ventricular arrhythmias, including premature ventricular contractions and sustained/non-sustained ventricular tachycardia; 4) acute myocardial infarction complicated by severe arrhythmias [1]